Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

20,943 public trials 4,006 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT05519085

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Local Institution - 0366 Los Alamitos, California, United States
  • Local Institution - 0272 San Diego, California, United States
  • Local Institution - 0273 West Hollywood, California, United States
  • Local Institution - 0381 Aurora, Colorado, United States
View all 266 locations
View Trial Details
Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

NCT05947851

Conditions
CLL, Chronic Disease, Disease Attributes, +18 more
Locations
  • Highlands Oncology Group ( Site 5405) Springdale, Arkansas, United States
  • MemorialCare Health System - Long Beach Medical Center ( Site 5421) Long Beach, California, United States
  • Memorial Hospital West ( Site 5410) Pembroke Pines, Florida, United States
  • Oregon Health and Science University ( Site 5425) Portland, Oregon, United States
View all 64 locations
View Trial Details
Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

NCT07192471

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • University of California, Irvine Medical Center - Hematology/Oncology Orange, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Beth Israel Deaconess Medical Center - Research Boston, Massachusetts, United States
  • Washington University School of Medicine - Oncology Hospital - Public St Louis, Missouri, United States
View all 22 locations
View Trial Details
Recruiting

A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT07455851

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Illawarra Cancer care centre, Wollongong Hospital Wollongong, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Recruiting

A Phase 2/3 Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

NCT06978725

Conditions
Cutaneous Sarcoidosis, Hemic and Lymphatic Diseases, Hypersensitivity, +5 more
Locations
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Durham, North Carolina, United States
  • Clinical Trial Site Philadelphia, Pennsylvania, United States
  • Clinical Trial Site Madison, Wisconsin, United States
View Trial Details
Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT06499285

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
View all 177 locations
View Trial Details
Recruiting

Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.

NCT07288489

Conditions
Blood Loss, Surgical, Cardiovascular Diseases, Coagulation Disorder, +9 more
Locations
  • Chandler Regional Medical Center (CRMC) Chandler, Arizona, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • HonorHealth John C Lincoln Medical Center Phoenix, Arizona, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 37 locations
View Trial Details
Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

NCT05554393

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 180 locations
View Trial Details
Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

NCT06317662

Conditions
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 114 locations
View Trial Details

Related conditions